Registration Deadline:
Vanderbilt Contact:
Explore other Industry Opportunities:
A targeted grant opportunity for MD/PhD candidates to translate scientific discoveries into potential medicines, providing comprehensive support for early-stage physician-scientists.
Overview
- Funding: Up to $100,000 in milestone-driven grant funding
- Additional Support: Personalized assistance from Harrington Discovery Institute's Therapeutics Development Center
- Maximum Potential Funding: Up to $750,000 per program upon reaching commercial milestones
- Project Duration: One year (potentially renewable for a second year)
Priority Areas
- Translational Medicine: Converting scientific discoveries into potential clinical applications
- Drug Development: Supporting promising independent research by MD/PhD candidates
- Medical Innovation: Advancing standard of care through scientific breakthroughs
Eligibility & Requirements
- Must be a Case Western Reserve University (CWRU) MSTP program student
- Candidates should begin funded award no later than fourth year of graduate training
- Requires submission of a brief Letter of Intent
- Special permission needed for projects initiated after fourth year
Timeline
- October 15, 2025: Award announcement and call for proposals
- November 12, 2025: Letter of Intent submission deadline
- Spring 2026: Award recipients selected and announced
Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.